drugset / Trial / NCT01472653
Treatment Selection According to Skin Reaction to Cetuximab
NaSingle-groupOpen-labelTreatment
Summary
The therapy of patients with locally advanced head and neck cancer will be adjusted to the grade of skin rush as recorded after the first two cycles of Cetuximab and Cisplatin, i.e. either with radioimmunotherapy (radiotherapy and Cetuximab) or radiochemotherapy (radiotherapy and Cisplatin.
Timeline
- Start
- 2011-12
- Primary completion
- 2014-03
- Completion
- 2016-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Cetuximab | Monoclonal antibody | 250 mg/m2 | Intravenous |
| Subject | Cisplatin | Other / unclassified | 30 mg/m2 | Intravenous |